{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:04:21Z","timestamp":1792008261257,"version":"4.4.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Behav Neurosci Rep"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s40473-019-00180-7","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T15:02:46Z","timestamp":1564066966000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Linking Late Life Depression and Alzheimer\u2019s Disease: Mechanisms and Resilience"],"prefix":"10.1007","volume":"6","author":[{"given":"Sara L.","family":"Weisenbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Hammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Konopacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Koppelmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"issue":"2","key":"180_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3233\/JAD-150603","volume":"51","author":"J Kida","year":"2016","unstructured":"\u2022 Kida J, Nemoto K, Ikejima C, Bun S, Kakuma T, Mizukami K, et al. Impact of depressive symptoms on conversion from mild cognitive impairment subtypes to Alzheimer\u2019s disease: a community-based longitudinal study. J Alzheimers Dis. 2016;51(2):405\u201315. A recent community-based longitudinal study of how depression in MCI increases risk for AD.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"180_CR2","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","volume":"63","author":"RL Ownby","year":"2006","unstructured":"Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006;63(5):530\u20138.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"180_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-151129","volume":"08;52","author":"Q Ye","year":"2016","unstructured":"\u2022 Ye Q, Bai F, Zhang Z. Shared genetic risk factors for late-life depression and Alzheimer\u2019s disease. J Alzheimers Dis. 2016;08;52(1):1\u201315. Meta-analysis of shared genetic risk for AD and LLD.","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"180_CR4","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1586\/ern.12.127","volume":"12","author":"AP Hermida","year":"2012","unstructured":"Hermida AP, McDonald WM, Steenland K, Levey A. The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link? Expert Rev Neurother. 2012;12(11):1339\u201350.","journal-title":"Expert Rev Neurother"},{"key":"180_CR5","unstructured":"United Nations, Department of Economics and Social Affairs, Population Division. World population ageing, 2017 highlights. 2017."},{"key":"180_CR6","unstructured":"World Health Organization. Depression and other common mental disorders: global health estimates [Internet]. 2017. Available from: \n                      https:\/\/www.who.int\/mental_health\/neurology\/dementia\/policy_guidance\/en\n                      \n                    . Accessed 19 July 2019."},{"issue":"1\u20133","key":"180_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jad.2012.05.010","volume":"142","author":"D B\u00fcchtemann","year":"2012","unstructured":"B\u00fcchtemann D, Luppa M, Bramesfeld A, Riedel-Heller S. Incidence of late-life depression: a systematic review. J Affect Disord. 2012 Dec 15;142(1\u20133):172\u20139.","journal-title":"J Affect Disord"},{"key":"180_CR8","unstructured":"World Health Organization. Towards a dementia plan: a WHO guide [Internet]. 2018. Available from: \n                      https:\/\/www.who.int\/mental_health\/neurology\/dementia\/policy_guidance\/en\/\n                      \n                    . Accessed 19 July 2019."},{"issue":"4","key":"180_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cger.2013.07.003","volume":"29","author":"R Roberts","year":"2013","unstructured":"Roberts R, Knopman DS. Classification and epidemiology of MCI. Clin Geriatr Med. 2013 Nov;29(4):753\u201372.","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"180_CR10","first-page":"93","volume":"375","author":"C Satizabal","year":"2016","unstructured":"\u2022 Satizabal C, Beiser AS, Seshadri S. Incidence of dementia over three decades in the Framingham Heart Study. N Engl J Med. 2016;375(1):93\u20134. One of the longest-running longitudinal studies of dementia risk.","journal-title":"N Engl J Med"},{"issue":"1","key":"180_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamapsychiatry.2016.3162","volume":"74","author":"Z Ismail","year":"2017","unstructured":"Ismail Z, Elbayoumi H, Fischer CE, Hogan DB, Millikin CP, Schweizer T, et al. Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74(1):58\u201367.","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"180_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrneurol.2017.63","volume":"13","author":"Y-T Wu","year":"2017","unstructured":"Wu Y-T, Beiser AS, Breteler MMB, Fratiglioni L, Helmer C, Hendrie HC, et al. The changing prevalence and incidence of dementia over time\u2014current evidence. Nat Rev Neurol. 2017;13(6):327\u201339.","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"180_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrneurol.2011.60","volume":"7","author":"AL Byers","year":"2011","unstructured":"Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011;7(6):323\u201331.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"180_CR14","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00213-016-4473-9","volume":"234","author":"M Xia","year":"2017","unstructured":"Xia M, Yang L, Sun G, Qi S, Li B. Mechanism of depression as a risk factor in the development of Alzheimer\u2019s disease: the function of AQP4 and the glymphatic system. Psychopharmacology. 2017;234(3):365\u201379.","journal-title":"Psychopharmacology"},{"issue":"3","key":"180_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4306\/pi.2017.14.3.271","volume":"14","author":"S-H Ryu","year":"2017","unstructured":"Ryu S-H, Jung H-Y, Lee KJ, Moon SW, Lee DW, Hong N, et al. Incidence and course of depression in patients with Alzheimer\u2019s disease. Psychiatry Investig. 2017;14(3):271\u201380.","journal-title":"Psychiatry Investig"},{"issue":"8","key":"180_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s12603-011-0061-1","volume":"15","author":"C Arbus","year":"2011","unstructured":"Arbus C, Gardette V, Cantet CE, Andrieu S, Nourhash\u00e9mi F, Schmitt L, et al. Incidence and predictive factors of depressive symptoms in Alzheimer\u2019s disease: the REAL.FR study. J Nutr Health Aging. 2011;15(8):609\u201317.","journal-title":"J Nutr Health Aging"},{"issue":"2","key":"180_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.maturitas.2014.05.009","volume":"79","author":"S Bennett","year":"2014","unstructured":"Bennett S, Thomas AJ. Depression and dementia: cause, consequence or coincidence? Maturitas. 2014;79(2):184\u201390.","journal-title":"Maturitas."},{"issue":"10","key":"180_CR18","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/gps.4926","volume":"33","author":"MM Gonzales","year":"2018","unstructured":"Gonzales MM, Insel PS, Nelson C, Tosun D, Sch\u00f6ll M, Mattsson N, et al. Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairment. Int J Geriatr Psychiatry. 2018;33(10):1305\u201311.","journal-title":"Int J Geriatr Psychiatry."},{"issue":"4","key":"180_CR19","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3233\/JAD-142955","volume":"46","author":"M Boccia","year":"2015","unstructured":"Boccia M, Acierno M, Piccardi L. Neuroanatomy of Alzheimer\u2019s disease and late-life depression: a coordinate-based meta-analysis of MRI studies. J Alzheimers Dis. 2015;46(4):963\u201370.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"180_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/gps.4489","volume":"32","author":"KD Harrington","year":"2017","unstructured":"Harrington KD, Gould E, Lim YY, Ames D, Pietrzak RH, Rembach A, et al. Amyloid burden and incident depressive symptoms in cognitively normal older adults. Int J Geriatr Psychiatry. 2017;32(4):455\u201363.","journal-title":"Int J Geriatr Psychiatry."},{"issue":"13","key":"180_CR21","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A. 1986;83(13):4913\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"36","key":"180_CR22","doi-asserted-by":"publisher","first-page":"14968","DOI":"10.1073\/pnas.1107411108","volume":"108","author":"JR Cirrito","year":"2011","unstructured":"Cirrito JR, Disabato BM, Restivo JL, Verges DK, Goebel WD, Sathyan A, et al. Serotonin signaling is associated with lower amyloid-\u03b2 levels and plaques in transgenic mice and humans. Proc Natl Acad Sci U S A. 2011;108(36):14968\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"180_CR23","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1007\/s00115-010-3129-y","volume":"82","author":"MA Rapp","year":"2011","unstructured":"Rapp MA, Hellweg R, Heinz A. The importance of depressive syndromes for incipient Alzheimer-type dementia in advanced age. Nervenarzt. 2011;82(9):1140\u20134.","journal-title":"Nervenarzt."},{"issue":"5","key":"180_CR24","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1001\/archpsyc.65.5.542","volume":"65","author":"X Sun","year":"2008","unstructured":"Sun X, Steffens DC, Au R, Folstein M, Summergrad P, Yee J, et al. Amyloid-associated depression: a prodromal depression of Alzheimer disease? Arch Gen Psychiatry. 2008;65(5):542\u201350.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"180_CR25","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-170001","volume":"59","author":"JR Gatchel","year":"2017","unstructured":"Gatchel JR, Donovan NJ, Locascio JJ, Schultz AP, Becker JA, Chhatwal J, et al. Depressive symptoms and tau accumulation in the inferior temporal lobe and entorhinal cortex in cognitively normal older adults: a pilot study. J Alzheimers Dis. 2017;59(3):975\u201385.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"180_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/0004867414557161","volume":"49","author":"KD Harrington","year":"2015","unstructured":"\u2022\u2022 Harrington KD, Lim YY, Gould E, Maruff P. Amyloid-beta and depression in healthy older adults: a systematic review. Aust N Z J Psychiatry. 2015;49(1):36\u201346. Review of studies investigating amyloid binding in LLD.","journal-title":"Aust N Z J Psychiatry"},{"key":"180_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fneur.2012.00063","volume":"3","author":"L Alves","year":"2012","unstructured":"Alves L, Correia ASA, Miguel R, Alegria P, Bugalho P. Alzheimer\u2019s disease: a clinical practice-oriented review. Front Neurol. 2012;3:63.","journal-title":"Front Neurol"},{"issue":"3","key":"180_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1515\/CCLM.2011.087","volume":"49","author":"D Prvulovic","year":"2011","unstructured":"Prvulovic D, Hampel H. Amyloid \u03b2 (A\u03b2) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer\u2019s disease. Clin Chem Lab Med. 2011;49(3):367\u201374.","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"180_CR29","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3233\/JAD-142931","volume":"45","author":"JK Chung","year":"2015","unstructured":"Chung JK, Plitman E, Nakajima S, Chow TW, Chakravarty MM, Caravaggio F, et al. Lifetime history of depression predicts increased amyloid-\u03b2 accumulation in patients with mild cognitive impairment. J Alzheimers Dis. 2015;45(3):907\u201319.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"180_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1001\/archpsyc.63.2.161","volume":"63","author":"MA Rapp","year":"2006","unstructured":"Rapp MA, Schnaider-Beeri M, Grossman HT, Sano M, Perl DP, Purohit DP, et al. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch Gen Psychiatry. 2006;63(2):161\u20137.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"180_CR31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/JGP.0b013e31816029ec","volume":"16","author":"MA Rapp","year":"2008","unstructured":"Rapp MA, Schnaider-Beeri M, Purohit DP, Perl DP, Haroutunian V, Sano M. Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression. Am J Geriatr Psychiatry. 2008;16(2):168\u201374.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"180_CR32","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3233\/JAD-160401","volume":"54","author":"EE Brown","year":"2016","unstructured":"\u2022\u2022 Brown EE, Iwata Y, Chung JK, Gerretsen P, Graff-Guerrero A. Tau in late-life depression: a systematic review and meta-analysis. J Alzheimers Dis. 2016;54(2):615\u201333. Review of studies investigating tau binding in LLD.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"180_CR33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3233\/JAD-160767","volume":"60","author":"SP Poulin","year":"2017","unstructured":"Poulin SP, Bergeron D, Dickerson BC, Alzheimer\u2019s Disease Neuroimaging Initiative. Risk factors, neuroanatomical correlates, and outcome of neuropsychiatric symptoms in Alzheimer\u2019s disease. J Alzheimers Dis. 2017;60(2):483\u201393.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"180_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1037\/neu0000223","volume":"30","author":"RS Wilson","year":"2016","unstructured":"Wilson RS, Boyle PA, Capuano AW, Shah RC, Hoganson GM, Nag S, et al. Late-life depression is not associated with dementia-related pathology. Neuropsychology. 2016;30(2):135\u201342.","journal-title":"Neuropsychology."},{"key":"180_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jad.2017.12.101","volume":"229","author":"S Perin","year":"2018","unstructured":"Perin S, Harrington KD, Lim YY, Ellis K, Ames D, Pietrzak RH, et al. Amyloid burden and incident depressive symptoms in preclinical Alzheimer\u2019s disease. J Affect Disord. 2018;229:269\u201374.","journal-title":"J Affect Disord"},{"issue":"1","key":"180_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-142940","volume":"46","author":"NJ Donovan","year":"2015","unstructured":"Donovan NJ, Hsu DC, Dagley AS, Schultz AP, Amariglio RE, Mormino EC, et al. Depressive symptoms and biomarkers of Alzheimer\u2019s disease in cognitively normal older adults. J Alzheimers Dis. 2015;46(1):63\u201373.","journal-title":"J Alzheimers Dis"},{"key":"180_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fnagi.2018.00038","volume":"10","author":"C Liguori","year":"2018","unstructured":"Liguori C, Pierantozzi M, Chiaravalloti A, Sancesario GM, Mercuri NB, Franchini F, et al. When cognitive decline and depression coexist in the elderly: CSF biomarkers analysis can differentiate Alzheimer\u2019s disease from late-life depression. Front Aging Neurosci. 2018;10:38.","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"180_CR38","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1017\/S1041610210002346","volume":"23","author":"CF Hybels","year":"2011","unstructured":"Hybels CF, Blazer DG, Landerman LR, Steffens DC. Heterogeneity in symptom profiles among older adults diagnosed with major depression. Int Psychogeriatr. 2011;23(6):906\u201322.","journal-title":"Int Psychogeriatr"},{"issue":"14","key":"180_CR39","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jama.1997.03550140078045","volume":"278","author":"BD Lebowitz","year":"1997","unstructured":"Lebowitz BD, Pearson JL, Schneider LS, Reynolds CF, Alexopoulos GS, Bruce ML, et al. Diagnosis and treatment of depression in late life. Consensus statement update. JAMA. 1997;278(14):1186\u201390.","journal-title":"JAMA."},{"key":"180_CR40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jad.2019.03.024","volume":"250","author":"T Ichikawa","year":"2019","unstructured":"Ichikawa T, Baba H, Maeshima H, Shimano T, Inoue M, Ishiguro M, et al. Serum levels of TDP-43 in late-life patients with depressive episode. J Affect Disord. 2019 01;250:284\u20138.","journal-title":"J Affect Disord"},{"issue":"11","key":"180_CR41","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1136\/jnnp.2006.104521","volume":"78","author":"RS Briellmann","year":"2007","unstructured":"Briellmann RS, Hopwood MJ, Jackson GD. Major depression in temporal lobe epilepsy with hippocampal sclerosis: clinical and imaging correlates. J Neurol Neurosurg Psychiatry. 2007;78(11):1226\u201330.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"180_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/archgenpsychiatry.2009.204","volume":"67","author":"YI Sheline","year":"2010","unstructured":"Sheline YI, Pieper CF, Barch DM, Welsh-Bohmer K, Welsh-Boehmer K, McKinstry RC, et al. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry. 2010;67(3):277\u201385.","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"180_CR43","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","volume":"62","author":"M Kivipelto","year":"2005","unstructured":"Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, K\u00e5reholt I, Winblad B, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005;62(10):1556\u201360.","journal-title":"Arch Neurol"},{"issue":"10","key":"180_CR44","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/archpsyc.1997.01830220033006","volume":"54","author":"GS Alexopoulos","year":"1997","unstructured":"Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. \u201cVascular depression\u201d hypothesis. Arch Gen Psychiatry. 1997;54(10):915\u201322.","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"180_CR45","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/mp.2013.20","volume":"18","author":"WD Taylor","year":"2013","unstructured":"Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry. 2013;18(9):963\u201374.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"180_CR46","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.biopsych.2012.10.028","volume":"73","author":"V Valkanova","year":"2013","unstructured":"Valkanova V, Ebmeier KP. Vascular risk factors and depression in later life: a systematic review and meta-analysis. Biol Psychiatry. 2013;73(5):406\u201313.","journal-title":"Biol Psychiatry"},{"issue":"4","key":"180_CR47","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1176\/appi.ajp.2007.07010175","volume":"165","author":"YI Sheline","year":"2008","unstructured":"Sheline YI, Price JL, Vaishnavi SN, Mintun MA, Barch DM, Epstein AA, et al. Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. Am J Psychiatry. 2008;165(4):524\u201332.","journal-title":"Am J Psychiatry"},{"issue":"13","key":"180_CR48","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1038\/npp.2015.158","volume":"40","author":"A Khalaf","year":"2015","unstructured":"Khalaf A, Edelman K, Tudorascu D, Andreescu C, Reynolds CF, Aizenstein H. White matter hyperintensity accumulation during treatment of late-life depression. Neuropsychopharmacology. 2015;40(13):3027\u201335.","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"180_CR49","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1017\/S0033291713001980","volume":"44","author":"RA Charlton","year":"2014","unstructured":"Charlton RA, Lamar M, Zhang A, Yang S, Ajilore O, Kumar A. White-matter tract integrity in late-life depression: associations with severity and cognition. Psychol Med. 2014;44(7):1427\u201337.","journal-title":"Psychol Med"},{"issue":"1\u20132","key":"180_CR50","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jns.2013.12.016","volume":"338","author":"W Li","year":"2014","unstructured":"Li W, Muftuler LT, Chen G, Ward BD, Budde MD, Jones JL, et al. Effects of the coexistence of late-life depression and mild cognitive impairment on white matter microstructure. J Neurol Sci. 2014;338(1\u20132):46\u201356.","journal-title":"J Neurol Sci"},{"issue":"4","key":"180_CR51","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1312889","volume":"370","author":"RS Doody","year":"2014","unstructured":"Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease. N Engl J Med. 2014;370(4):311\u201321.","journal-title":"N Engl J Med"},{"issue":"1","key":"180_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13195-017-0318-y","volume":"9","author":"S Ostrowitzki","year":"2017","unstructured":"Ostrowitzki S, Lasser RA, Dorflinger E, Scheltens P, Barkhof F, Nikolcheva T, et al. A phase III randomized trial of gantenerumab in prodromal Alzheimer\u2019s disease. Alzheimers Res Ther. 2017;9(1):95.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"180_CR53","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa1304839","volume":"370","author":"S Salloway","year":"2014","unstructured":"Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease. N Engl J Med. 2014;370(4):322\u201333.","journal-title":"N Engl J Med"},{"issue":"1","key":"180_CR54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13195-016-0189-7","volume":"8","author":"R Vandenberghe","year":"2016","unstructured":"Vandenberghe R, Rinne JO, Boada M, Katayama S, Scheltens P, Vellas B, et al. Bapineuzumab for mild to moderate Alzheimer\u2019s disease in two global, randomized, phase 3 trials. Alzheimers Res Ther. 2016;8(1):18.","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"180_CR55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","volume":"11","author":"ND Prins","year":"2015","unstructured":"Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol. 2015;11(3):157\u201365.","journal-title":"Nat Rev Neurol"},{"issue":"17","key":"180_CR56","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/WNL.0b013e318217e7a4","volume":"76","author":"J Li","year":"2011","unstructured":"\u2022\u2022 Li J, Wang YJ, Zhang M, Xu ZQ, Gao CY, Fang CQ, et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology. 2011;76(17):1485\u201391. Meta-analysis of extent to which vascular health conditions predict conversion of MCI to AD.","journal-title":"Neurology."},{"issue":"5","key":"180_CR57","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp-2014-310095","volume":"87","author":"J-Q Li","year":"2016","unstructured":"Li J-Q, Tan L, Wang H-F, Tan M-S, Tan L, Xu W, et al. Risk factors for predicting progression from mild cognitive impairment to Alzheimer\u2019s disease: a systematic review and meta-analysis of cohort studies. J Neurol Neurosurg Psychiatry. 2016;87(5):476\u201384.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"180_CR58","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/WAD.0000000000000043","volume":"29","author":"N Lorius","year":"2015","unstructured":"Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Viswanathan A, et al. Vascular disease and risk factors are associated with cognitive decline in the Alzheimer disease spectrum. Alzheimer Dis Assoc Disord. 2015;29(1):18\u201325.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"7","key":"180_CR59","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jamaneurol.2014.667","volume":"71","author":"G Tosto","year":"2014","unstructured":"Tosto G, Zimmerman ME, Carmichael OT, Brickman AM, Alzheimer\u2019s Disease Neuroimaging Initiative. Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities. JAMA Neurol. 2014;71(7):872\u20137.","journal-title":"JAMA Neurol"},{"issue":"2","key":"180_CR60","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1172\/JCI97509","volume":"128","author":"S Strickland","year":"2018","unstructured":"Strickland S. Blood will out: vascular contributions to Alzheimer\u2019s disease. J Clin Invest. 2018;128(2):556\u201363.","journal-title":"J Clin Invest"},{"key":"180_CR61","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.neuron.2019.01.014","volume":"101","author":"M Merlini","year":"2019","unstructured":"Merlini M, Rafalski VA, Rios Coronado PE, Gill TM, Ellisman M, Muthukumar G, et al. Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer\u2019s disease model. Neuron. 2019; [EPub ahead of print;101:1099\u20131108.e6.","journal-title":"Neuron."},{"issue":"9","key":"180_CR62","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/jamaneurol.2015.1359","volume":"72","author":"NM Gregg","year":"2015","unstructured":"Gregg NM, Kim AE, Gurol ME, Lopez OL, Aizenstein HJ, Price JC, et al. Incidental cerebral microbleeds and cerebral blood flow in elderly individuals. JAMA Neurol. 2015;72(9):1021\u20138.","journal-title":"JAMA Neurol."},{"issue":"2","key":"180_CR63","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jalz.2013.04.507","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Zhu Y-S, Khan MA, Brunk E, Martin-Cook K, Weiner MF, et al. Global brain hypoperfusion and oxygenation in amnestic mild cognitive impairment. Alzheimers Dement. 2014;10(2):162\u201370.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"180_CR64","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3233\/JAD-170181","volume":"59","author":"L Beishon","year":"2017","unstructured":"Beishon L, Haunton VJ, Panerai RB, Robinson TG. Cerebral hemodynamics in mild cognitive impairment: a systematic review. J Alzheimers Dis. 2017;59(1):369\u201385.","journal-title":"J Alzheimers Dis"},{"key":"180_CR65","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Herman FJ, Simkovic S, Pasinetti GM. Neuroimmune nexus of depression and dementia: shared mechanisms and therapeutic targets. Br J Pharmacol. 2019. \n                      https:\/\/doi.org\/10.1111\/bph.14569\n                      \n                    . Review of neuroinflammatory mechanisms underlying depression and dementia..","DOI":"10.1111\/bph.14569"},{"key":"180_CR66","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bbi.2015.11.011","volume":"55","author":"LE Santos","year":"2016","unstructured":"Santos LE, Beckman D, Ferreira ST. Microglial dysfunction connects depression and Alzheimer\u2019s disease. Brain Behav Immun. 2016;55:151\u201365.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"180_CR67","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1073\/pnas.0708092105","volume":"105","author":"JW Koo","year":"2008","unstructured":"Koo JW, Duman RS. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A. 2008;105(2):751\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"180_CR68","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acps.12698","volume":"135","author":"CA K\u00f6hler","year":"2017","unstructured":"\u2022\u2022 K\u00f6hler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand. 2017;135(5):373\u201387. Meta-analysis of inflammation in depression.","journal-title":"Acta Psychiatr Scand"},{"key":"180_CR69","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharmthera.2016.04.001","volume":"163","author":"HO Kalkman","year":"2016","unstructured":"Kalkman HO, Feuerbach D. Antidepressant therapies inhibit inflammation and microglial M1-polarization. Pharmacol Ther. 2016;163:82\u201393.","journal-title":"Pharmacol Ther"},{"key":"180_CR70","first-page":"447","volume":"8","author":"ES Wohleb","year":"2014","unstructured":"Wohleb ES, McKim DB, Sheridan JF, Godbout JP. Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior. Front Neurosci. 2014;8:447.","journal-title":"Front Neurosci"},{"issue":"2","key":"180_CR71","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","volume":"50","author":"F Brosseron","year":"2014","unstructured":"Brosseron F, Krauthausen M, Kummer M, Heneka MT. Body fluid cytokine levels in mild cognitive impairment and Alzheimer\u2019s disease: a comparative overview. Mol Neurobiol. 2014;50(2):534\u201344.","journal-title":"Mol Neurobiol"},{"issue":"10","key":"180_CR72","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/jnnp-2017-316201","volume":"88","author":"KSP Lai","year":"2017","unstructured":"\u2022\u2022 Lai KSP, Liu CS, Rau A, Lanct\u00f4t KL, K\u00f6hler CA, Pakosh M, et al. Peripheral inflammatory markers in Alzheimer\u2019s disease: a systematic review and meta-analysis of 175 studies. J Neurol Neurosurg Psychiatry. 2017;88(10):876\u201382. Meta-analysis of inflammation in AD.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"180_CR73","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1192\/bjp.bp.116.190165","volume":"209","author":"L Su","year":"2016","unstructured":"Su L, Faluyi YO, Hong YT, Fryer TD, Mak E, Gabel S, et al. Neuroinflammatory and morphological changes in late-life depression: the NIMROD study. Br J Psychiatry. 2016;209(6):525\u20136.","journal-title":"Br J Psychiatry"},{"issue":"3","key":"180_CR74","first-page":"792","volume":"140","author":"Z Fan","year":"2017","unstructured":"\u2022 Fan Z, Brooks DJ, Okello A, Edison P. An early and late peak in microglial activation in Alzheimer\u2019s disease trajectory. Brain. 2017;140(3):792\u2013803. Document trajectory of neuroinflammation in MCI and AD.","journal-title":"Brain."},{"issue":"2","key":"180_CR75","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.bbr.2012.07.026","volume":"235","author":"JK Soczynska","year":"2012","unstructured":"Soczynska JK, Mansur RB, Brietzke E, Swardfager W, Kennedy SH, Woldeyohannes HO, et al. Novel therapeutic targets in depression: minocycline as a candidate treatment. Behav Brain Res. 2012;235(2):302\u201317.","journal-title":"Behav Brain Res"},{"key":"180_CR76","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jad.2017.10.042","volume":"227","author":"JD Rosenblat","year":"2018","unstructured":"Rosenblat JD, McIntyre RS. Efficacy and tolerability of minocycline for depression: a systematic review and meta-analysis of clinical trials. J Affect Disord. 2018;227:219\u201325.","journal-title":"J Affect Disord"},{"issue":"3","key":"180_CR77","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s11682-014-9325-9","volume":"9","author":"EA Boots","year":"2015","unstructured":"Boots EA, Schultz SA, Oh JM, Larson J, Edwards D, Cook D, et al. Cardiorespiratory fitness is associated with brain structure, cognition, and mood in a middle-aged cohort at risk for Alzheimer\u2019s disease. Brain Imaging Behav. 2015;9(3):639\u201349.","journal-title":"Brain Imaging Behav"},{"issue":"3","key":"180_CR78","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1001\/archneur.58.3.498","volume":"58","author":"D Laurin","year":"2001","unstructured":"Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol. 2001;58(3):498\u2013504.","journal-title":"Arch Neurol"},{"issue":"3","key":"180_CR79","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1037\/0278-6133.26.3.341","volume":"26","author":"C Wrosch","year":"2007","unstructured":"Wrosch C, Schulz R, Miller GE, Lupien S, Dunne E. Physical health problems, depressive mood, and cortisol secretion in old age: buffer effects of health engagement control strategies. Health Psychol. 2007;26(3):341\u20139.","journal-title":"Health Psychol"},{"issue":"1","key":"180_CR80","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jalz.2005.11.004","volume":"2","author":"HC Hendrie","year":"2006","unstructured":"Hendrie HC, Albert MS, Butters MA, Gao S, Knopman DS, Launer LJ, et al. The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee. Alzheimers Dement. 2006;2(1):12\u201332.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"180_CR81","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/gps.1870","volume":"23","author":"Y Lee","year":"2008","unstructured":"Lee Y, Park K. Does physical activity moderate the association between depressive symptoms and disability in older adults? Int J Geriatr Psychiatry. 2008;23(3):249\u201356.","journal-title":"Int J Geriatr Psychiatry."},{"issue":"4","key":"180_CR82","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1037\/0278-6133.19.4.339","volume":"19","author":"GM Williamson","year":"2000","unstructured":"Williamson GM. Extending the activity restriction model of depressed affect: evidence from a sample of breast cancer patients. Health Psychol. 2000;19(4):339\u201347.","journal-title":"Health Psychol"},{"issue":"2","key":"180_CR83","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1037\/0882-7974.19.2.362","volume":"19","author":"Y Benyamini","year":"2004","unstructured":"Benyamini Y, Lomranz J. The relationship of activity restriction and replacement with depressive symptoms among older adults. Psychol Aging. 2004;19(2):362\u20136.","journal-title":"Psychol Aging"},{"issue":"20","key":"180_CR84","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1212\/01.wnl.0000271087.67782.cb","volume":"13;69","author":"RS Wilson","year":"2007","unstructured":"Wilson RS, Scherr PA, Schneider JA, Tang Y, Bennett DA. Relation of cognitive activity to risk of developing Alzheimer disease. Neurology. 2007;13;69(20):1911\u201320.","journal-title":"Neurology"},{"issue":"3","key":"180_CR85","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1037\/0882-7974.14.3.483","volume":"14","author":"C Schooler","year":"1999","unstructured":"Schooler C, Mulatu MS, Oates G. The continuing effects of substantively complex work on the intellectual functioning of older workers. Psychol Aging. 1999;14(3):483\u2013506.","journal-title":"Psychol Aging"},{"issue":"25","key":"180_CR86","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1056\/NEJMoa022252","volume":"348","author":"J Verghese","year":"2003","unstructured":"Verghese J, Lipton RB, Katz MJ, Hall CB, Derby CA, Kuslansky G, et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med. 2003 19;348(25):2508\u201316.","journal-title":"N Engl J Med"},{"issue":"5","key":"180_CR87","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1532-5415.1995.tb06093.x","volume":"43","author":"C Fabrigoule","year":"1995","unstructured":"Fabrigoule C, Letenneur L, Dartigues JF, Zarrouk M, Commenges D, Barberger-Gateau P. Social and leisure activities and risk of dementia: a prospective longitudinal study. J Am Geriatr Soc. 1995;43(5):485\u201390.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"180_CR88","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1207\/S15327965PLI1303_04","volume":"13","author":"LK George","year":"2002","unstructured":"George LK, Ellison CG, Larson DB. Explaining the relationships between religious involvement and health. Psychol Inq. 2002;13(3):190\u2013200.","journal-title":"Psychol Inq"},{"issue":"1","key":"180_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-142766","volume":"48","author":"DS Khalsa","year":"2015","unstructured":"Khalsa DS. Stress, meditation, and Alzheimer\u2019s disease prevention: where the evidence stands. J Alzheimers Dis. 2015;48(1):1\u201312.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"180_CR90","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/JGP.0b013e3181a88441","volume":"17","author":"V Isaac","year":"2009","unstructured":"Isaac V, Stewart R, Artero S, Ancelin M-L, Ritchie K. Social activity and improvement in depressive symptoms in older people: a prospective community cohort study. Am J Geriatr Psychiatry. 2009;17(8):688\u201396.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"12","key":"180_CR91","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/gps.2676","volume":"26","author":"WJ Dickinson","year":"2011","unstructured":"Dickinson WJ, Potter GG, Hybels CF, McQuoid DR, Steffens DC. Change in stress and social support as predictors of cognitive decline in older adults with and without depression. Int J Geriatr Psychiatry. 2011;26(12):1267\u201374.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"9212","key":"180_CR92","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/S0140-6736(00)02107-3","volume":"5;355","author":"LF Berkman","year":"2000","unstructured":"Berkman LF. Which influences cognitive function: living alone or being alone? Lancet. 2000;5;355(9212):1291\u20132.","journal-title":"Lancet"},{"issue":"2","key":"180_CR93","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1080\/13825585.2017.1414769","volume":"26","author":"ML Zuelsdorff","year":"2019","unstructured":"Zuelsdorff ML, Koscik RL, Okonkwo OC, Peppard PE, Hermann BP, Sager MA, et al. Social support and verbal interaction are differentially associated with cognitive function in midlife and older age. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2019;26(2):144\u201360.","journal-title":"Neuropsychol Dev Cogn B Aging Neuropsychol Cogn"},{"issue":"11","key":"180_CR94","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1176\/appi.ajp.158.11.1850","volume":"158","author":"JC Hays","year":"2001","unstructured":"Hays JC, Steffens DC, Flint EP, Bosworth HB, George LK. Does social support buffer functional decline in elderly patients with unipolar depression? Am J Psychiatry. 2001;158(11):1850\u20135.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"180_CR95","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1017\/S1041610205000979","volume":"17","author":"DC Steffens","year":"2005","unstructured":"Steffens DC, Pieper CF, Bosworth HB, MacFall JR, Provenzale JM, Payne ME, et al. Biological and social predictors of long-term geriatric depression outcome. Int Psychogeriatr. 2005;17(1):41\u201356.","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"180_CR96","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/PSY.0b013e31827f09cd","volume":"75","author":"A Shankar","year":"2013","unstructured":"Shankar A, Hamer M, McMunn A, Steptoe A. Social isolation and loneliness: relationships with cognitive function during 4 years of follow-up in the English Longitudinal Study of Ageing. Psychosom Med. 2013;75(2):161\u201370.","journal-title":"Psychosom Med"},{"issue":"3","key":"180_CR97","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/gerona\/59.3.M268","volume":"59","author":"RS Tilvis","year":"2004","unstructured":"Tilvis RS, K\u00e4h\u00f6nen-V\u00e4re MH, Jolkkonen J, Valvanne J, Pitkala KH, Strandberg TE. Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci. 2004;59(3):268\u201374.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"9212","key":"180_CR98","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/S0140-6736(00)02113-9","volume":"15;355","author":"L Fratiglioni","year":"2000","unstructured":"Fratiglioni L, Wang HX, Ericsson K, Maytan M, Winblad B. Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet. 2000;15;355(9212):1315\u20139.","journal-title":"Lancet"},{"issue":"11","key":"180_CR99","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","volume":"11","author":"Y Stern","year":"2012","unstructured":"Stern Y. Cognitive reserve in ageing and Alzheimer\u2019s disease. Lancet Neurol. 2012 Nov;11(11):1006\u201312.","journal-title":"Lancet Neurol"},{"issue":"19","key":"180_CR100","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1212\/WNL.0000000000000964","volume":"83","author":"OC Okonkwo","year":"2014","unstructured":"Okonkwo OC, Schultz SA, Oh JM, Larson J, Edwards D, Cook D, et al. Physical activity attenuates age-related biomarker alterations in preclinical AD. Neurology. 2014;83(19):1753\u201360.","journal-title":"Neurology."},{"issue":"12","key":"180_CR101","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1212\/WNL.0000000000002490","volume":"86","author":"P Vemuri","year":"2016","unstructured":"\u2022 Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Machulda M, Lowe VJ, et al. Effect of intellectual enrichment on AD biomarker trajectories: longitudinal imaging study. Neurology. 2016;86(12):1128\u201335. Longitudinal study of effect of cognitive enrichment on appearance of AD biomarkers.","journal-title":"Neurology."},{"issue":"9","key":"180_CR102","first-page":"CD004366","volume":"12","author":"GM Cooney","year":"2013","unstructured":"Cooney GM, Dwan K, Greig CA, Lawlor DA, Rimer J, Waugh FR, et al. Exercise for depression. Cochrane Database Syst Rev. 2013;12(9):CD004366.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"180_CR103","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/07317115.2018.1516263","volume":"42","author":"S An","year":"2019","unstructured":"An S, Jung H, Lee S. Moderating effects of community social capital on depression in later years of life: a latent interaction model. Clin Gerontol. 2019;42(1):70\u20139.","journal-title":"Clin Gerontol"},{"issue":"2\u20133","key":"180_CR104","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0165-0327(93)90026-G","volume":"29","author":"RC Kessler","year":"1993","unstructured":"Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey. I: lifetime prevalence, chronicity and recurrence. J Affect Disord. 1993 Nov;29(2\u20133):85\u201396.","journal-title":"J Affect Disord"},{"issue":"6","key":"180_CR105","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1212\/WNL.49.6.1498","volume":"49","author":"S Seshadri","year":"1997","unstructured":"Seshadri S, Wolf PA, Beiser A, Au R, McNulty K, White R, et al. Lifetime risk of dementia and Alzheimer\u2019s disease. The impact of mortality on risk estimates in the Framingham Study. Neurology. 1997;49(6):1498\u2013504.","journal-title":"Neurology."},{"issue":"1\u20132","key":"180_CR106","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jnr.23827","volume":"95","author":"CJ Pike","year":"2017","unstructured":"Pike CJ. Sex and the development of Alzheimer\u2019s disease. J Neurosci Res. 2017;95(1\u20132):671\u201380.","journal-title":"J Neurosci Res"},{"key":"180_CR107","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.pnpbp.2018.08.026","volume":"89","author":"L Ma","year":"2019","unstructured":"Ma L, Xu Y, Wang G, Li R. What do we know about sex differences in depression: a review of animal models and potential mechanisms. Prog Neuro-Psychopharmacol Biol Psychiatry. 2019 08;89:48\u201356.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1","key":"180_CR108","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"GBD 2016","year":"2019","unstructured":"GBD 2016. Dementia Collaborators. Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):88\u2013106.","journal-title":"Lancet Neurol"},{"issue":"1\u20132","key":"180_CR109","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000109498","volume":"29","author":"AS Buchman","year":"2007","unstructured":"Buchman AS, Wilson RS, Boyle PA, Bienias JL, Bennett DA. Grip strength and the risk of incident Alzheimer\u2019s disease. Neuroepidemiology. 2007;29(1\u20132):66\u201373.","journal-title":"Neuroepidemiology."},{"issue":"10","key":"180_CR110","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1212\/01.WNL.0000162054.15428.E9","volume":"64","author":"N Scarmeas","year":"2005","unstructured":"Scarmeas N, Albert M, Brandt J, Blacker D, Hadjigeorgiou G, Papadimitriou A, et al. Motor signs predict poor outcomes in Alzheimer disease. Neurology. 2005;64(10):1696\u2013703.","journal-title":"Neurology."},{"issue":"6","key":"180_CR111","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jamda.2015.12.092","volume":"17","author":"O Beauchet","year":"2016","unstructured":"Beauchet O, Annweiler C, Callisaya ML, De Cock A-M, Helbostad JL, Kressig RW, et al. Poor gait performance and prediction of dementia: results from a meta-analysis. J Am Med Dir Assoc. 2016;17(6):482\u201390.","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"180_CR112","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1023\/A:1024569803230","volume":"27","author":"LL Carstensen","year":"2003","unstructured":"Carstensen LL, Fung HH, Charles ST. Socioemotional selectivity theory and the regulation of emotion in the second half of life. Motiv Emot. 2003;27(2):103\u201323.","journal-title":"Motiv Emot"},{"issue":"4","key":"180_CR113","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1037\/0882-7974.22.4.765","volume":"22","author":"S-M Chow","year":"2007","unstructured":"Chow S-M, Hamagani F, Nesselroade JR. Age differences in dynamical emotion-cognition linkages. Psychol Aging. 2007;22(4):765\u201380.","journal-title":"Psychol Aging"},{"issue":"4","key":"180_CR114","doi-asserted-by":"publisher","first-page":"P216","DOI":"10.1093\/geronb\/62.4.P216","volume":"62","author":"SD Neupert","year":"2007","unstructured":"Neupert SD, Almeida DM, Charles ST. Age differences in reactivity to daily stressors: the role of personal control. J Gerontol B Psychol Sci Soc Sci. 2007;62(4):P216\u201325.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"issue":"8","key":"180_CR115","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.paid.2005.12.009","volume":"40","author":"N Garnefski","year":"2006","unstructured":"Garnefski N, Kraaij V. Relationships between cognitive emotion regulation strategies and depressive symptoms: a comparative study of five specific samples. Personal Individ Differ. 2006;40(8):1659\u201369.","journal-title":"Personal Individ Differ"},{"issue":"3","key":"180_CR116","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.brs.2016.03.010","volume":"9","author":"T Perera","year":"2016","unstructured":"Perera T, George MS, Grammer G, Janicak PG, Pascual-Leone A, Wirecki TS. The clinical TMS society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimul. 2016;9(3):336\u201346.","journal-title":"Brain Stimul"},{"issue":"2","key":"180_CR117","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/gps.4982","volume":"34","author":"JU Kim","year":"2019","unstructured":"Kim JU, Weisenbach SL, Zald DH. Ventral prefrontal cortex and emotion regulation in aging: a case for utilizing transcranial magnetic stimulation. Int J Geriatr Psychiatry. 2019;34(2):215\u201322.","journal-title":"Int J Geriatr Psychiatry."},{"issue":"2","key":"180_CR118","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1212\/WNL.0b013e31823efcbb","volume":"78","author":"P Newhouse","year":"2012","unstructured":"Newhouse P, Kellar K, Aisen P, White H, Wesnes K, Coderre E, et al. Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial. Neurology. 2012;78(2):91\u2013101.","journal-title":"Neurology."},{"key":"180_CR119","doi-asserted-by":"publisher","unstructured":"Gandelman JA, Kang H, Antal A, Albert K, Boyd BD, Conley AC, et al. Transdermal nicotine for the treatment of mood and cognitive symptoms in nonsmokers with late-life depression. J Clin Psychiatry. 2018;79(5). \n                      https:\/\/doi.org\/10.4088\/JCP.18m12137\n                      \n                    .","DOI":"10.4088\/JCP.18m12137"}],"container-title":["Current Behavioral Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40473-019-00180-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40473-019-00180-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40473-019-00180-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T23:41:18Z","timestamp":1595547678000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40473-019-00180-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["180"],"URL":"https:\/\/doi.org\/10.1007\/s40473-019-00180-7","relation":{},"ISSN":["2196-2979"],"issn-type":[{"value":"2196-2979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,25]]},"assertion":[{"value":"25 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Sara Weisenbach reports grants from National Institutes of Health outside the submitted work. The other authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}